Cannabis Delta-8 THC better harm-reduction tool than popular delta-9 THC, study suggests In spite of warnings from major agencies on the dangers of delta-8 THC, researchers say it has therapeutic potential Natalia Buendia CalvilloNovember 25, 2021
News US DEA set to authorize potent pot production for research With only one approved US university supplying low-quality cannabis for decades, the DEA says it will finally open up licensing Jared GnamMay 18, 2021
News MindMed stock surges on Nasdaq listing approval After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company Jared GnamApril 23, 2021
Industry update Low-THC weed led to poor results in major PTSD study US researchers seek DEA to permit potent pot production after long-awaited FDA-backed study shows weak weed ineffective at treating PTSD Jared GnamMarch 30, 2021
Industry update Charlotte’s Web bounces back in Q4 American CBD market leader reports 2020 sales of US$95.2M and positive results for a third-party liver toxicity study Jared GnamMarch 25, 2021
Industry update US FDA unveils plan to gather ‘real-world’ data to fill CBD research gaps After two years of delaying regulations, the agency looks to improve data-gathering methods on CBD product safety Jared GnamJanuary 11, 2021
Industry update Dousing strawberries in CBD oil reduces mould, extends shelf life: study Research from the University of South Florida suggests CBD has promising potential as an antimicrobial treatment for fresh produce Jared GnamDecember 10, 2020
The weed wire FDA’s new draft guidelines could speed up CBD drug approvals As industry players await full regulations, the US federal agency continues to slowly open up the CBD market Jared GnamSeptember 29, 2020
The weed wire Canopy launches Martha Stewart CBD line in cluttered US market Canadian weed titan hopes Stewart's celebrity power will catapult it above the 3,000 brands in the US CBD space Jared GnamSeptember 10, 2020
COVID-19 Revive Therapeutics approved by FDA for Phase 3 trial of possible Covid-19 treatment Shares of the novel drug developer jumped 68% Friday on the news Jared GnamJuly 31, 2020